Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping

Journal of Clinical Virology

Volumn 39, Issue 2, 2007, Pages 125-131

  Chen, J H K ^a   Wong, K H ^b   Chan, K ^b   Lam, H Y ^a   Lee, S S ^c   Li, P ^d   Lee, M P ^d   Tsang, D N ^d   Zheng, B J ^a   Yuen, K Y ^a   Yam, W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

CRF01_AE; Drug resistance; Genotyping resistance test; HIV 1; In house

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; PHYLOGENY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS IDENTIFICATION; VIRUS RECOMBINANT; VIRUS STRAIN;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; GENETIC TECHNIQUES; GENOTYPE; HIV-1; HONG KONG; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 34248639310     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.03.008     Document Type: Article

References (29)

1. Ariyoshi K., Matsuda M., Miura H., Tateishi S., Yamada K., and Sugiura W. Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. J Acquir Immune Defic Syndr 33 (2003) 336-342
2. Beddows S., Galpin S., Kazmi S.H., Ashraf A., Johargy A., Frater A.J., et al. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type1 group M subtypes. J Med Virol 70 (2003) 337-342
3. Caride E., Brindeiro R., Hertogs K., Larder B., Dehertogh P., Machado E., et al. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virology 275 (2000) 107-115
4. Carpenter C.C., Cooper D.A., Fischl M.A., Gatell J.M., Gazzard D.A., Hammer S.M., et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society, USA Panel. J Am Med Assoc 283 (2000) 381-390
5. deOliveira T., Deforche K., Cassol S., Salminen M., Paraskevis D., Seebregts C., et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21 (2005) 3797-3800
6. Eshleman S.H., Hackett Jr. J., Swanson P., Cunningham S.P., Drews B., Brennan C., et al. Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J Clin Microbiol 42 (2004) 2711-2717
7. The EuroGuidelines Group for HIV resistance, and EuroGuidelines Group for HIV Resistance. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. AIDS 15 (2001) 309-320
8. Fontaine E., Riva C., Peeters M., Schmit J.C., Delaporte E., Van Laethem K., et al. Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type1 subtypes A through J. J Acquir Immune Defic Syndr 28 (2001) 254-258
9. Gifford R., deOliveira T., Rambaut A., Myers R.E., Gale C.V., Dunn D., et al. Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity. AIDS 20 (2006) 1521-1529
10. Grant R.M., Kuritzkes D.R., Johnson V.A., Mellors J.W., Sullivan J.L., Swanstrom R., et al. Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol 41 (2003) 1586-1593
11. Hirsch M.S., Brun-Vezinet F., D'Aquila R.T., Hammer S.M., Johnson V.A., Kuritzkes D.R., et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA 283 (2000) 2417-2426
12. Jagodzinski L.L., Cooley J.D., Weber M., and Michael N.L. Performance characteristics of human immunodeficiency virus type 1 (HIV-1) genotyping systems in sequence-based analysis of subtypes other than HIV-1 subtype B. J Clin Microbiol 41 (2003) 998-1003
13. Johnson V.A., Brun-Vezinet F., Clotet B., Kuritzkes D.R., Pillay D., Schapiro J.M., et al. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med 14 (2006) 125-130
14. Kumar S., Tamura K., and Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5 (2004) 150-163
15. Kwok S., and Higushi R. Avoiding false positives with PCR. Nature 339 (1989) 227-238
16. Laeyendecker O., Zhang G.W., Quinn T.C., Garten R., Ray S.C., Lai S., et al. Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 38 (2005) 356-362
17. Lindstrom A., and Albert J. A simple and sensitive 'in-house' method for determining genotypic drug resistance of HIV-1. J Virol Methods 107 (2003) 45-51
18. McCutchan F.E. Global epidemiology of HIV. J Med Virol 78 (2006) S7-S12
19. Mracna M., Becker-Pergola G., Dileanis J., Guay L.A., Cunningham S., Jackson J.B., et al. Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda. J Clin Microbiol 39 (2001) 4323-4327
20. Njouom R., Pasquier C., Sandres-Saune K., Harter A., Souyris C., and Izopet J. Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences. J Virol Methods 110 (2003) 1-8
21. Pasquier C., Millot N., Njouom R., Sandres K., Cazabat M., Puel J., et al. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 94 (2001) 45-54
22. Roche Diagnostic Systems. AMPLICOR HIV-1 MONITOR Test Package Insert. Roche Diagnostic Systems, Branchburg, NJ, 1996;8-9.
23. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4 (1987) 406-425
24. Staden R., Beal K.F., and Bonfield J.K. The Staden package, 1998. Methods Mol Biol 132 (2000) 115-130
25. Steegen K., Demecheleer E., De Cabooter N., Nges D., Temmerman M., Ndumbe P., et al. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. J Virol Methods 133 (2006) 137-145
26. Sturmer M., Preiser W., Gute P., Nisius G., and Doerr H.W. Phylogenetic analysis of HIV-1 transmission: pol gene sequences are sufficient to clarify true relationships between patient isolates. AIDS 18 (2004) 2109-2113
27. Swanson P., Devare S.G., and Hackett Jr. J. Molecular characterization of 39 HIV isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 19 (2003) 625-629
28. Tovanabutra S., Beyrer C., Sakkhachornphop S., Razak M.H., Ramos G.L., Vongchak T., et al. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999-2002. AIDS Res Hum Retroviruses 20 (2004) 465-475
29. Yam W.C., Chen J.H.K., Wong K.H., Chan K., Cheng V.C.C., Lam H.Y., et al. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong. J Clin Virol 35 (2006) 454-457